Skip to content
Screener

Danaher DHR High-growth markets — Sales

Other geography segments

North America
$2.47B+1.5%
Western Europe
$1.54B+2.2%
Other developed markets
$293M-0.3%

Similar metrics at other companies

Veralto logo
VLTOHigh-growth markets — Sales
$388M+2.9%
Envista Holdings Corporation logo
NVSTEmerging markets — Sales
$166M+10.4%
Envista Holdings Corporation logo
NVSTOther developed markets — Sales
$34.5M+16.2%
Veralto logo
VLTOOther developed markets — Sales
$33M+13.8%
ITG
ITGROther Markets — Sales
$9.58M-47.3%
GTL
GTLSChina — Sales
$125.35M-11.3%

Other financials

Income statement

See full
Revenue$6.3B+5.5%
Gross profit$3.6B+2.5%
Operating income$1.1B+48.3%
Net income$870.0M+56.8%
EPS (diluted)$1.23+59.7%

Balance sheet

See full
Cash & equivalents$4.3B+47.0%
Total debt$27.9B+50.1%
Total equity$52.6B+0.5%
Total assets$92.4B+13.2%

Cash flow

See full
Operating cash flow$1.5B+14.6%
CapEx$269.0M+8.5%
Free cash flow$1.3B+16.1%

Valuation

See full
Market cap$140.36B+0.4%
Enterprise value$163.87B+5.5%
P/E35.1×-5.9×
P/S5.6×-0.2×

Profitability

See full
Gross margin58.5%-1.1pp
Operating margin20.4%+2.0pp
Net margin15.9%+1.7pp
FCF margin21.8%+1.5pp

Returns & leverage

See full
Return on equity7.6%+1.0pp
Debt / equity0.5×+0.2×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Danaher in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Danaher’s 10-Q, filed July 21, 2026.

Filed
Jul 20, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000313616-26-000161
For the Three-Month Period Ended June 26, 2026:Biotechnology / For the Three-Month Period Ended June 26, 2026:Life SciencesDiagnosticsTotal
North America(a)$583$759$1,132$2,474
Western Europe6894214301,540
Other developed markets(b)7412693293
High-growth markets(c)5745738111,958
Total$1,920$1,879$2,466$6,265
Revenue type:
Recurring$1,722$1,268$2,210$5,200
Nonrecurring1986112561,065

Item 1. Financial Statements

FAQ

What is Danaher's high-growth markets — sales?
Danaher (DHR) reported high-growth markets — sales of $1.96B in Q2 2026.
How has Danaher's high-growth markets — sales changed year-over-year?
Danaher's high-growth markets — sales increased by 15.4% year-over-year, from $1.7B to $1.96B.
What is the long-term trend for Danaher's high-growth markets — sales?
Over 4 years (2021 to 2025), Danaher's high-growth markets — sales has grown at a -2.5% compound annual growth rate (CAGR), from $7.77B to $7.02B.
What does high-growth markets — sales mean?
This metric represents the total revenue generated from geographic regions identified as emerging or developing economies. These markets are characterized by sustained periods of accelerated gross domestic product growth and ongoing infrastructure development. It serves as a key indicator of the company's ability to capture market share in regions with high long-term expansion potential.

Ask your AI about Danaher's high-growth markets — sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude